Davide Gianni
Impact in
- Molecular Biology top 5%
- Protein Degradation and Inhibitors
- RNA Interference and Gene Delivery
- Ubiquitin and proteasome pathways
- Genetics top 5%
- Virus-based gene therapy research
Papers in
-
- RNA Interference and Gene Delivery 7
- CRISPR and Genetic Engineering 6
- Physiology 14
- Nitric Oxide and Endothelin Effects 6
- Alzheimer's disease research and treatments 6
- Co-authors
- Gary Bokoch (7 shared papers)Nicolas Taulet (3 shared papers)Celine M. DerMardirossian (3 shared papers)Giulia Fulci (4 shared papers)Sara A. Courtneidge (2 shared papers)Ennio Antonio Chiocca (4 shared papers)Miguel Sena‐Esteves (8 shared papers)Ralph Weissleder (3 shared papers)
- Journals
- SLAS DISCOVERY (8 papers)Molecular Therapy (3 papers)Journal of Biological Chemistry (3 papers)Proceedings of the National Academy of Sciences (2 papers)Circulation (2 papers)
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
Davide Gianni
62 papers receiving 3.4k citations
Davide Gianni's Hit Papers
Peers
Comparison fields: 5 of 114
- Molecular Biology 2.0k
- Genetics 777
- Immunology 519
- Physiology 529
- Oncology 534
Countries citing papers authored by Davide Gianni
This map shows the geographic impact of Davide Gianni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davide Gianni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davide Gianni more than expected).
Fields of papers citing papers by Davide Gianni
This network shows the impact of papers produced by Davide Gianni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davide Gianni. The network helps show where Davide Gianni may publish in the future.
Co-authors
The 25 scholars most cited alongside Davide Gianni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Transcriptional plasticity promotes primary and acquired resistance to BET inhibition Hit paper breakdown → | 2015 | 432 |
| 2 | 2006 | 308 | |
| 3 | 2012 | 255 | |
| 4 | 2010 | 171 | |
| 5 | 2007 | 150 | |
| 6 | 2012 | 121 | |
| 7 | 2010 | 115 | |
| 8 | 2008 | 111 | |
| 9 | 2008 | 103 | |
| 10 | 2009 | 97 | |
| 11 | 2017 | 94 | |
| 12 | 2010 | 94 | |
| 13 | 2004 | 85 | |
| 14 | 2006 | 75 | |
| 15 | 2003 | 73 | |
| 16 | 2015 | 72 | |
| 17 | 2021 | 71 | |
| 18 | 2008 | 67 | |
| 19 | 2015 | 64 | |
| 20 | 2013 | 63 |
About Davide Gianni
Davide Gianni is a scholar working on Molecular Biology, Physiology, Genetics, Immunology and Oncology, having authored 65 papers that have together received 3.4k indexed citations. Recurring topics across this work include Virus-based gene therapy research (11 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (8 papers), RNA Interference and Gene Delivery (7 papers), CAR-T cell therapy research (6 papers), Nitric Oxide and Endothelin Effects (6 papers), Alzheimer's disease research and treatments (6 papers), CRISPR and Genetic Engineering (6 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). The work is most often cited by research in Molecular Biology (2.0k citations), Genetics (777 citations), Immunology (519 citations), Physiology (529 citations) and Oncology (534 citations). Davide Gianni has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Gary Bokoch, Nicolas Taulet, Celine M. DerMardirossian, Giulia Fulci, Sara A. Courtneidge, Ennio Antonio Chiocca, Miguel Sena‐Esteves, Ralph Weissleder, Balveen Kaur and Federica del Monte. Their work appears in journals such as SLAS DISCOVERY, Molecular Therapy, Journal of Biological Chemistry, Proceedings of the National Academy of Sciences and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.